TITLE

Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2

AUTHOR(S)
Reverter, David; Fernández-Catalán, Carlos; Baumgartner, Roland; Pfänder, Ruth; Huber, Robert; Bode, Wolfram; Vendrell, Josep; Holak, Tad A.; Avilés, Francesc X.
PUB. DATE
April 2000
SOURCE
Nature Structural Biology;Apr2000, Vol. 7 Issue 4, p322
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Leech carboxypeptidase inhibitor (LCI) is a novel protein inhibitor present in the medicinal leech Hirudo medicinalis. The structures of LCI free and bound to carboxypeptidase A2 (CPA2)have been determined by NMR and X-ray crystallography, respectively. The LCI structure defines a new protein motif that comprises a five-stranded antiparallel β-sheet and one short α-helix. This structure is preserved in the complex with human CPA2 in the X-ray structure, where the contact regions between the inhibitor and the protease are defined. The C-terminal tail of LCI becomes rigid upon binding the protease as shown in the NMR relaxation studies, and it interacts with the carboxypeptidase in a substrate-like manner. The homology between the C-terminal tails of LCI and the potato carboxypeptidase inhibitor represents a striking example of convergent evolution dictated by the target protease. These new structures are of biotechnological interest since they could elucidate the control mechanism of metallo-carboxypeptidases and could be used as lead compounds for the search of fibrinolytic drugs.
ACCESSION #
8816532

 

Related Articles

  • Structure- and Fragment-Based Approaches to Protease Inhibition. Johnson, Sherida L.; Pellecchia, Maurizio // Current Topics in Medicinal Chemistry;Feb2006, Vol. 6 Issue 4, p317 

    Proteases are essential enzymes which regulate physiological processes such as inflammation, infection, fertilization, allergic reactions, cell growth and death, blood clotting, tumor growth and bone remodeling. The protease family consists of six major classes of enzymes which are aspartic-,...

  • Protein NMR spectroscopy in structural genomics. Montelione, Gaetano T.; Zheng, Deyou; Huang, Yuanpeng J.; Gunsalus, Kristin C.; Szyperski, Thomas // Nature Structural Biology;Nov2000 Supplement, Vol. 7, p982 

    Protein NMR spectroscopy provides an important complement to X-ray crystallography for structural genomics, both for determining three-dimensional protein structures and in characterizing their biochemical and biophysical functions.

  • Structural genomics projects in Japan. Yokoyama, Shigeyuki; Hirota, Hiroshi; Kigawa, Takanori; Yabuki, Takashi; Shirouzu, Mikako; Terada, Takaho; Ito, Yutaka; Matsuo, Yo; Kuroda, Yutaka; Nishimura, Yoshifumi; Kyogoku, Yoshimasa; Miki, Kunio; Masui, Ryoji; Kuramitsu, Seiki // Nature Structural Biology;Nov2000 Supplement, Vol. 7, p943 

    Two major structural genomics projects exist in Japan. The oldest, the RIKEN Structural Genomics Initiative, has two major goals: to determine bacterial, mammalian, and plant protein structures by X-ray crystallography and NMR spectroscopy and to perform functional analyses with the target...

  • Prediction of Protein Disorder at the Domain Level. Dosztanyi, Zsuzsanna; Sandor, Mark; Tompa, Peter; Simon, Istvan // Current Protein & Peptide Science;Apr2007, Vol. 8 Issue 2, p161 

    Intrinsically disordered/unstructured proteins exist in a highly flexible conformational state largely devoid of secondary structural elements and tertiary contacts. Despite their lack of a well defined structure, these proteins often fulfill essential regulatory functions. The intrinsic lack of...

  • Diversity Breeds Leads. Stoll, Vincent S. // Drug Discovery & Development;Dec2008, Vol. 11 Issue 12, p16 

    The article explores the value of the structured-based drug design programs in the U.S. Relevant to this, enzymatic or affinity-based fragment screening is accordingly obtained through utilization of protein nuclear magnetic resonance (NMR) and X-ray crystallography in screening the...

  • Probing solid iminobis(diorganophosphine chalcogenide) systems with multinuclear magnetic resonance. Demko, Bryan A.; Wasylishen, Roderick E. // Canadian Journal of Chemistry;Jan2009, Vol. 87 Issue 1, p348 

    A 31P and 77Se solid-state NMR investigation of the iminobis(diorganophosphine chalcogenide) HN(R2PE)2 (R = Ph,iPr; E = O, S, Se) systems is presented. The NMR results are discussed in terms of the known HN(R2PE)2 structures available from X-ray crystallography. The phosphorus chemical shift...

  • Hexaethylbenzene complexes of ruthenium and manganese — X-ray crystal structures and NMR spectra of [(HEB)2Ru2(µ-Cl)3][C5(CO2Me)5], [(HEB)Ru(H2O)3][BF4]2, (HEB)RuCl2[P(OMe)3], trans-RuCl2(PMe3)4, and (HEB)Mn(CO)2Br Gupta, Hari K.; Lock, Philippa E.; Reginato, Nada; Britten, James F.; McGlinchey, Michael J. // Canadian Journal of Chemistry;Feb2006, Vol. 84 Issue 2, p277 

    Hexaethylbenzene (HEB) and [(p-cymene)RuCl2]2 react in the melt to yield [(HEB)RuCl2]2 (6), the NMR spectra of which reveal the presence of [(HEB)2Ru2(µ-Cl)3]Cl in solution. In [(HEB)2Ru2(µ-Cl)3][C5(CO2Me)5] (7), the cation has D3h symmetry with alternating proximal and distal ethyl...

  • Structures and Optical Properties of Hydrazones Derived from Biological Polyenes. Nakashima, Takayasu; Yamada, Takashi; Hashimoto, Hideki; Kobayashi, Takayoshi // International Journal of Modern Physics B: Condensed Matter Phys;12/10/2001, Vol. 15 Issue 28-30, p3893 

    A set of hydrazone molecules was derived from a series of biological polyenes that have different polyene chain-lengths with common substituent group of 2,4-dinitrophenylhydrazine. Their structures were determined by high-resolution NMR spectroscopy as well as X-ray crystallography, and their...

  • Origin of Chiral Pharmacology Stereochemistry in Metalloprotease Inhibition. Kim, D.H. // Mini Reviews in Medicinal Chemistry;Jul2001, Vol. 1 Issue 2, p155 

    The stereospecificity shown by a wide variety of inhibitors that are effective for carboxypeptidase A (CPA), a representative zinc protease is analyzed on the basis of inhibitor type. In cases of ground state analog inhibitors and transition state analog inhibitors, the stereoisomers having the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics